Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2005 4
2006 3
2007 2
2008 5
2009 8
2010 8
2011 8
2012 10
2013 10
2014 10
2015 10
2016 18
2017 11
2018 17
2019 16
2020 7
2021 8
2022 5
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

149 results
Results by year
Filters applied: . Clear all
Page 1
Idiopathic pulmonary fibrosis.
Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU. Martinez FJ, et al. Among authors: swigris jj. Nat Rev Dis Primers. 2017 Oct 20;3:17074. doi: 10.1038/nrdp.2017.74. Nat Rev Dis Primers. 2017. PMID: 29052582 Review.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. Raghu G, et al. Among authors: swigris jj. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL. Am J Respir Crit Care Med. 2011. PMID: 21471066 Free PMC article.
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. Among authors: swigris jj. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.
Managing Cough in Idiopathic Pulmonary Fibrosis.
Wakwaya Y, Ramdurai D, Swigris JJ. Wakwaya Y, et al. Among authors: swigris jj. Chest. 2021 Nov;160(5):1774-1782. doi: 10.1016/j.chest.2021.05.071. Epub 2021 Jun 23. Chest. 2021. PMID: 34171385 Review.
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V; “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. Fischer A, et al. Among authors: swigris jj. Eur Respir J. 2015 Oct;46(4):976-87. doi: 10.1183/13993003.00150-2015. Epub 2015 Jul 9. Eur Respir J. 2015. PMID: 26160873 Free article.
Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome.
de Boer E, Petrache I, Goldstein NM, Olin JT, Keith RC, Modena B, Mohning MP, Yunt ZX, San-Millán I, Swigris JJ. de Boer E, et al. Among authors: swigris jj. Am J Respir Crit Care Med. 2022 Jan 1;205(1):126-129. doi: 10.1164/rccm.202108-1903LE. Am J Respir Crit Care Med. 2022. PMID: 34665688 Free PMC article. No abstract available.
Response.
Solomon JJ, Swigris JJ, Demoruelle MK. Solomon JJ, et al. Among authors: swigris jj. Chest. 2020 Oct;158(4):1778-1779. doi: 10.1016/j.chest.2020.07.048. Chest. 2020. PMID: 33036088 No abstract available.
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).
Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. Corte TJ, et al. Among authors: swigris jj. BMJ Open Respir Res. 2021 Dec;8(1):e001026. doi: 10.1136/bmjresp-2021-001026. BMJ Open Respir Res. 2021. PMID: 34969771 Free PMC article. Clinical Trial.
The 4-min mile and supplemental oxygen in IPF.
Swigris JJ. Swigris JJ. Respirology. 2020 Nov;25(11):1114-1115. doi: 10.1111/resp.13890. Epub 2020 Jun 22. Respirology. 2020. PMID: 32573005 Free article. No abstract available.
149 results